Insulin-like growth factor binding protein-3 is overexpressed in endothelial cells of mouse breast tumor vessels

Michael C. Schmid, Marco Bisoffi, Antoinette Wetterwald, Elsbeth Gautschi, George N. Thalmann, Stefania Mitola, Federico Bussolino, Marco G. Cecchini

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Angiogenesis is a key process in a variety of human diseases, including cancer. The ability to target selectively the tumor vasculature is potentially useful for the diagnosis and treatment of cancer. Still, little information is available regarding markers that are restricted to the ECs of tumor vessels. cDNA array technology allows simultaneous analysis of relative expression levels of a broad spectrum of genes in 2 related cell populations. We used this technology with the aim of identifying markers specific for TECs. TECs were isolated by CD31-mediated immunomagnetic separation from tumors induced by s.c. injection of NF9006 breast carcinoma cells into syngeneic mice. NECs were isolated from lactating mammary glands. The endothelial nature of isolated cells was confirmed by RT-PCR using CD31-specific primers and by uptake of Dil-Ac-LDL. Macrophage contamination in the EC isolations could be reasonably ruled out by assessing the expression of the macrophage marker c-fms. 32P-labeled cDNA probes generated by reverse transcription from total RNA were hybridized to mouse-specific gene arrays. Several genes consistently showed differential expression between TECs and NECs. However, expression of only 1 of these genes, IGFBP-3, was restricted exclusively to ECs. Semiquantitative RT-PCR revealed 22- to 33-fold differential expression of IGFBP-3 in the TEC fraction. IGFBP-3 was overexpressed by a factor of 5 in an additional mouse model of breast carcinoma induced by 4T1.2 tumor cells. These results indicate that IGFBP-3 is a potential novel marker of angiogenesis. Elucidation of its role in tumor neovascularization may open the possibility of IGFBP-3 as a therapeutic target for antiangiogenesis.

Original languageEnglish
Pages (from-to)577-586
Number of pages10
JournalInternational Journal of Cancer
Volume103
Issue number5
DOIs
Publication statusPublished - Feb 20 2003

Fingerprint

Insulin-Like Growth Factor Binding Protein 3
Endothelial Cells
Breast Neoplasms
Neoplasms
Genes
Macrophages
Immunomagnetic Separation
Technology
Polymerase Chain Reaction
Human Mammary Glands
Oligonucleotide Array Sequence Analysis
Reverse Transcription
Complementary DNA
RNA
Injections
Therapeutics
Population

Keywords

  • Angiogenesis
  • Antiangiogenesis
  • Gene profile
  • IGFBP-3
  • Tumor endothelium

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Schmid, M. C., Bisoffi, M., Wetterwald, A., Gautschi, E., Thalmann, G. N., Mitola, S., ... Cecchini, M. G. (2003). Insulin-like growth factor binding protein-3 is overexpressed in endothelial cells of mouse breast tumor vessels. International Journal of Cancer, 103(5), 577-586. https://doi.org/10.1002/ijc.10874

Insulin-like growth factor binding protein-3 is overexpressed in endothelial cells of mouse breast tumor vessels. / Schmid, Michael C.; Bisoffi, Marco; Wetterwald, Antoinette; Gautschi, Elsbeth; Thalmann, George N.; Mitola, Stefania; Bussolino, Federico; Cecchini, Marco G.

In: International Journal of Cancer, Vol. 103, No. 5, 20.02.2003, p. 577-586.

Research output: Contribution to journalArticle

Schmid, MC, Bisoffi, M, Wetterwald, A, Gautschi, E, Thalmann, GN, Mitola, S, Bussolino, F & Cecchini, MG 2003, 'Insulin-like growth factor binding protein-3 is overexpressed in endothelial cells of mouse breast tumor vessels', International Journal of Cancer, vol. 103, no. 5, pp. 577-586. https://doi.org/10.1002/ijc.10874
Schmid, Michael C. ; Bisoffi, Marco ; Wetterwald, Antoinette ; Gautschi, Elsbeth ; Thalmann, George N. ; Mitola, Stefania ; Bussolino, Federico ; Cecchini, Marco G. / Insulin-like growth factor binding protein-3 is overexpressed in endothelial cells of mouse breast tumor vessels. In: International Journal of Cancer. 2003 ; Vol. 103, No. 5. pp. 577-586.
@article{2d9047683a924f7cbb8c80ad71b9d8d9,
title = "Insulin-like growth factor binding protein-3 is overexpressed in endothelial cells of mouse breast tumor vessels",
abstract = "Angiogenesis is a key process in a variety of human diseases, including cancer. The ability to target selectively the tumor vasculature is potentially useful for the diagnosis and treatment of cancer. Still, little information is available regarding markers that are restricted to the ECs of tumor vessels. cDNA array technology allows simultaneous analysis of relative expression levels of a broad spectrum of genes in 2 related cell populations. We used this technology with the aim of identifying markers specific for TECs. TECs were isolated by CD31-mediated immunomagnetic separation from tumors induced by s.c. injection of NF9006 breast carcinoma cells into syngeneic mice. NECs were isolated from lactating mammary glands. The endothelial nature of isolated cells was confirmed by RT-PCR using CD31-specific primers and by uptake of Dil-Ac-LDL. Macrophage contamination in the EC isolations could be reasonably ruled out by assessing the expression of the macrophage marker c-fms. 32P-labeled cDNA probes generated by reverse transcription from total RNA were hybridized to mouse-specific gene arrays. Several genes consistently showed differential expression between TECs and NECs. However, expression of only 1 of these genes, IGFBP-3, was restricted exclusively to ECs. Semiquantitative RT-PCR revealed 22- to 33-fold differential expression of IGFBP-3 in the TEC fraction. IGFBP-3 was overexpressed by a factor of 5 in an additional mouse model of breast carcinoma induced by 4T1.2 tumor cells. These results indicate that IGFBP-3 is a potential novel marker of angiogenesis. Elucidation of its role in tumor neovascularization may open the possibility of IGFBP-3 as a therapeutic target for antiangiogenesis.",
keywords = "Angiogenesis, Antiangiogenesis, Gene profile, IGFBP-3, Tumor endothelium",
author = "Schmid, {Michael C.} and Marco Bisoffi and Antoinette Wetterwald and Elsbeth Gautschi and Thalmann, {George N.} and Stefania Mitola and Federico Bussolino and Cecchini, {Marco G.}",
year = "2003",
month = "2",
day = "20",
doi = "10.1002/ijc.10874",
language = "English",
volume = "103",
pages = "577--586",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "5",

}

TY - JOUR

T1 - Insulin-like growth factor binding protein-3 is overexpressed in endothelial cells of mouse breast tumor vessels

AU - Schmid, Michael C.

AU - Bisoffi, Marco

AU - Wetterwald, Antoinette

AU - Gautschi, Elsbeth

AU - Thalmann, George N.

AU - Mitola, Stefania

AU - Bussolino, Federico

AU - Cecchini, Marco G.

PY - 2003/2/20

Y1 - 2003/2/20

N2 - Angiogenesis is a key process in a variety of human diseases, including cancer. The ability to target selectively the tumor vasculature is potentially useful for the diagnosis and treatment of cancer. Still, little information is available regarding markers that are restricted to the ECs of tumor vessels. cDNA array technology allows simultaneous analysis of relative expression levels of a broad spectrum of genes in 2 related cell populations. We used this technology with the aim of identifying markers specific for TECs. TECs were isolated by CD31-mediated immunomagnetic separation from tumors induced by s.c. injection of NF9006 breast carcinoma cells into syngeneic mice. NECs were isolated from lactating mammary glands. The endothelial nature of isolated cells was confirmed by RT-PCR using CD31-specific primers and by uptake of Dil-Ac-LDL. Macrophage contamination in the EC isolations could be reasonably ruled out by assessing the expression of the macrophage marker c-fms. 32P-labeled cDNA probes generated by reverse transcription from total RNA were hybridized to mouse-specific gene arrays. Several genes consistently showed differential expression between TECs and NECs. However, expression of only 1 of these genes, IGFBP-3, was restricted exclusively to ECs. Semiquantitative RT-PCR revealed 22- to 33-fold differential expression of IGFBP-3 in the TEC fraction. IGFBP-3 was overexpressed by a factor of 5 in an additional mouse model of breast carcinoma induced by 4T1.2 tumor cells. These results indicate that IGFBP-3 is a potential novel marker of angiogenesis. Elucidation of its role in tumor neovascularization may open the possibility of IGFBP-3 as a therapeutic target for antiangiogenesis.

AB - Angiogenesis is a key process in a variety of human diseases, including cancer. The ability to target selectively the tumor vasculature is potentially useful for the diagnosis and treatment of cancer. Still, little information is available regarding markers that are restricted to the ECs of tumor vessels. cDNA array technology allows simultaneous analysis of relative expression levels of a broad spectrum of genes in 2 related cell populations. We used this technology with the aim of identifying markers specific for TECs. TECs were isolated by CD31-mediated immunomagnetic separation from tumors induced by s.c. injection of NF9006 breast carcinoma cells into syngeneic mice. NECs were isolated from lactating mammary glands. The endothelial nature of isolated cells was confirmed by RT-PCR using CD31-specific primers and by uptake of Dil-Ac-LDL. Macrophage contamination in the EC isolations could be reasonably ruled out by assessing the expression of the macrophage marker c-fms. 32P-labeled cDNA probes generated by reverse transcription from total RNA were hybridized to mouse-specific gene arrays. Several genes consistently showed differential expression between TECs and NECs. However, expression of only 1 of these genes, IGFBP-3, was restricted exclusively to ECs. Semiquantitative RT-PCR revealed 22- to 33-fold differential expression of IGFBP-3 in the TEC fraction. IGFBP-3 was overexpressed by a factor of 5 in an additional mouse model of breast carcinoma induced by 4T1.2 tumor cells. These results indicate that IGFBP-3 is a potential novel marker of angiogenesis. Elucidation of its role in tumor neovascularization may open the possibility of IGFBP-3 as a therapeutic target for antiangiogenesis.

KW - Angiogenesis

KW - Antiangiogenesis

KW - Gene profile

KW - IGFBP-3

KW - Tumor endothelium

UR - http://www.scopus.com/inward/record.url?scp=0037455811&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037455811&partnerID=8YFLogxK

U2 - 10.1002/ijc.10874

DO - 10.1002/ijc.10874

M3 - Article

C2 - 12494464

AN - SCOPUS:0037455811

VL - 103

SP - 577

EP - 586

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 5

ER -